Evidence map›Paper›PMID 29164957›Full record

Observational studyThe European journal of general practice2018

Expectations, concerns, and needs of patients who start drugs for chronic conditions. A prospective observational study among community pharmacies in Serbia.

Katarina M Vučićević, Branislava R Miljković, Bojana C Golubović, Marija N Jovanović, Sandra D Vezmar Kovačević, Milica D Ćulafić, Milena M Kovačević, Johan J de Gier

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in The European journal of general practice, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Katarina M Vučićevića Department of Pharmacokinetics and Clinical Pharmacy, Faculty of Pharmacy , University of Belgrade , Belgrade , Serbia.
Branislava R Miljkovića Department of Pharmacokinetics and Clinical Pharmacy, Faculty of Pharmacy , University of Belgrade , Belgrade , Serbia.
Bojana C Golubovića Department of Pharmacokinetics and Clinical Pharmacy, Faculty of Pharmacy , University of Belgrade , Belgrade , Serbia.
Marija N Jovanovića Department of Pharmacokinetics and Clinical Pharmacy, Faculty of Pharmacy , University of Belgrade , Belgrade , Serbia.
Sandra D Vezmar Kovačevića Department of Pharmacokinetics and Clinical Pharmacy, Faculty of Pharmacy , University of Belgrade , Belgrade , Serbia.
Milica D Ćulafića Department of Pharmacokinetics and Clinical Pharmacy, Faculty of Pharmacy , University of Belgrade , Belgrade , Serbia.
Milena M Kovačevića Department of Pharmacokinetics and Clinical Pharmacy, Faculty of Pharmacy , University of Belgrade , Belgrade , Serbia.
Johan J de Gierb Department of Pharmacotherapy and Pharmaceutical Care , University of Groningen , Groningen , The Netherlands.
University of Belgrade · RSUniversity of Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDuring the initiation of treatment of a chronic disease, patients may have varying interests, expectations, concerns, and reasons to stop treatment, influencing compliance with prescribed treatment. Thus, healthcare professionals are expected to integrate these needs into medicines management.

objectivesTo determine what information is important to patients; assess predictors of patients' interests, expectations, concerns, reasons to stop therapy; evaluate drug-related problems following initiation of therapy and summarize how pharmacists resolve them during patient-pharmacist counselling.

methodsIn 2014, a four-month study was performed in Serbian community pharmacies, as part of the Pharmaceutical Care Quality Indicators Project led by the European Directorate for the Quality of Medicines & Healthcare. Seventy community pharmacists were asked to participate in the study. Pharmacists recruited adult patients who consented to participate in the study and who initiated treatment, lasting at least six months. Patients completed an open-ended questions form. After two-to-four weeks, a patient-pharmacist consultation was performed.

resultsForty-four community pharmacists (response rate 62.9%) sent back the completed forms from 391 patients (response rate 67.1%). The total number of dispensed drugs was 403. In terms of drug safety, 29.4% of patients sought information, 32.5% expressed concerns, and 28.1% of patients cited it as a reason to discontinue treatment. During the first weeks of therapy, 18% of patients experienced practical problems, while 27.3% reported adverse drug reactions.

conclusionSafety issues are a major focus of patients' prescribed new medicines for long-term treatment.

Indexed as

Health Services Needs and DemandAdultChronic DiseaseCommunity Pharmacy ServicesDrug-Related Side Effects and Adverse ReactionsHumansMedication AdherenceNeeds AssessmentPharmacistsPrescription DrugsProspective StudiesSerbiaPrescription Drugscommunity pharmacylong-term treatmentpatient–pharmacist counsellingSafety

Identifiers

PMID29164957
PMCPMC5774285
OpenAlexW2768511842

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.